View more job listings or post a job
Catalent Pharma Solutions - San Diego Position OverviewJob DescriptionCatalent hires people with a passion to make a difference to the health of millions of people globally. Your expertise, coupled with Catalent’s advance
Denali Therapeutics Principal Scientist, DMPK (small molecule therapeutics)
Sorrento Therapeutics Scientist/Senior Scientist, LC-MS
Takeda Principal Scientist, DMPK Project Representative, Oligos, Cell Therapy, Biologics
Cytokinetics Director/Sr. Director DMPK
Longboard Pharmaceuticals Director of ADME
CCS Associates, Inc. Senior Scientist, Immunology
TLL Pharma, High Impact Medicines for All.  Director of Formulation Development
Post a job


[Free Online Symposium] Drug-Drug Interaction - Industry Trends and the 2020 FDA Guidances

Speakers: Scott Obach (Pfizer), David Boudet (Theravance), Honghui Zhou (Johnson & Johnson), Xinning Yang (FDA), Bo Feng (Vertex) and Marciej Zamek-Gliszczynski (GSK)
Organizers: Tracy Chen (Jazz) and Snow Ge (QED)
Date: 2021-09-23- 09/24/2021
Time: 8:30-12:30 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor: (2)BioIVT; Sekisui XenoTech, LLC
Vendor show vendors registered to date:
Registration deadline:2021-09-22  (it will close sooner if the seating cap is reached)

About the Topic

Note: the meeting times are 8:30am - 12:30pm Pacific Time on Sept 23 and 24. 

Drug interaction is an important consideration throughout drug development.  Since each drug candidate has its unique drug interaction profile in the context of the intended indication, there are no universally accepted strategies for evaluating drug interaction potentials; however, but there are generally adopted drug interaction strategies and practices developed by the industry and regulatory authorities such as the US FDA. 

The goal of this meeting is to provide:
1) a basic introduction to drug interactions
2) a detailed discussion on the 2020 FDA drug interaction guidances
3) a series of case studies on drug interactions involving drug transporters and metabolizing enzymes. 

The speakers are leaders in the field of drug interactions from the FDA and the Pharma/Biotech industry and are involved with the IQ Consortium DDI Working Group and/or the International Transporter Consortium.


Symposium Agenda – Day 1

8:30 - 8:45 am (PST) / 11:30 - 11:45 am (EST)            Introductions - Cuiping Chen (Jazz)

8:45 - 9:45 am (PST) / 11:45 - 12:45 am (EST)            In vitro CYP-mediated DDI - Scott Obach (Pfizer)

9:45 - 10:45 am (PST) / 12:45 - 1:45 pm (EST)           Therapeutic protein-drug interactions: mechanisms and clinical relevance - Honghui Zhou (Janssen/JNJ)

10:45 - 10:55 am (PST) / 1:45 - 1:55 pm (EST)           Major Sponsor Presentation - BioIVT

10:55 – 11:10 am (PST) / 1:55 - 2:10 pm (EST)           Break

11:10 - 12:10 am (PST) / 2:10 - 3:10 pm (EST)           In vivo CYP-mediated clinical DDI - David Bourdet (Theravance)

12:10 - 12:45 pm (PST) / 3:10 - 3:45 pm (EST)           Panel Discussion Day 1 - All Speakers, moderated by Cuiping Chen (Jazz Pharmaceuticals) 

Symposium Agenda – Day 2

8:30 - 8:45 am (PST) / 11:30 - 11:45 am (EST)            Welcome Remarks - Snow Ge (QED Therapeutics)

8:45 - 9:45 am (PST) / 11:45 - 12:45 am (EST)            Transporter DDI risk assessment – A preclinical perspective - Bo Feng (Vertex)

9:45 - 10:45 am (PST) / 12:45 - 1:45 pm (EST)           In vivo transporter–mediated DDI - Maciej Zamek-Gliszczynski (GSK)

10:45 - 10:55 am (PST) / 1:45 - 1:55 pm (EST)           Major Sponsor Presentation - Sekisui XenoTech

10:55 – 11:10 am (PST) / 1:55 - 2:10 pm (EST)           Break

11:10 - 12:10 am (PST) / 2:10 - 3:10 pm (EST)           FDA’s perspective on the DDI guidance - Xinning Yang

12:10 - 12:45 pm (PST) / 3:10 - 3:45 pm (EST)           Panel Discussion Day 2  - All Speakers, moderated by Snow (QED Therapeutics )

2021-11-03, [Free Online Workshop] Nonclinical Reproductive Toxicity Studies: Fundamentals, Regulatory Trends and Case Studies
2021-11-17, [Free Online Symposium] Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery
2021-12-07, [Free Online Seminar] Fighting pancreatic cancer: current treatments, pipeline landscape, and PanCAN's drug development projects
┬ęPharmaceutical & BioScience Society, International; Last Modified: 9/18/2021; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Hypha Discovery Limited Synthesis, purification & NMR characterization of drug metabolites at mg-g scale with COAs, including CYP/AOX/FMO metabolites, glucuronides & sulfates
Applied StemCell, Inc. Fresh & frozen human PBMCs, CD34+ cells, NK cells, T cells & more. Customized sample collection and Bay Area same-day delivery are available.
iPRECIO Programmable Pumps by Primetech Corporation Unprecedented PK-PD correlations in in-Vivo Pharmacology? Learn more on Linkedin- registration page. iPRECIO Programmable pump info at
Applied StemCell, Inc. Fresh & frozen non-human primate whole blood, PBMCs, T cells & more from cynomolgus & rhesus macaques. Animals housed in the U.S., Call 1-866-497-4180
Submit a Text Ad